HTGM - HTG Molecular Diagnostics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
42.48M
Enterprise Value 3
12.32M
Trailing P/E
N/A
Forward P/E 1
-1.98
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.98
Price/Book (mrq)
1.80
Enterprise Value/Revenue 3
0.57
Enterprise Value/EBITDA 6
-0.79

Trading Information

Stock Price History

Beta (3Y Monthly) 2.10
52-Week Change 3-77.23%
S&P500 52-Week Change 38.78%
52 Week High 34.2700
52 Week Low 30.6000
50-Day Moving Average 30.7904
200-Day Moving Average 31.6094

Share Statistics

Avg Vol (3 month) 3301.36k
Avg Vol (10 day) 3129.73k
Shares Outstanding 558.03M
Float 22.43M
% Held by Insiders 17.75%
% Held by Institutions 151.30%
Shares Short (Sep 30, 2019) 42.77M
Short Ratio (Sep 30, 2019) 46.54
Short % of Float (Sep 30, 2019) 413.29%
Short % of Shares Outstanding (Sep 30, 2019) 49.64%
Shares Short (prior month Aug 30, 2019) 42.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -79.96%
Operating Margin (ttm)-78.82%

Management Effectiveness

Return on Assets (ttm)-25.10%
Return on Equity (ttm)-88.16%

Income Statement

Revenue (ttm)21.43M
Revenue Per Share (ttm)0.75
Quarterly Revenue Growth (yoy)18.00%
Gross Profit (ttm)3.99M
EBITDA -15.6M
Net Income Avi to Common (ttm)-17.14M
Diluted EPS (ttm)-0.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.57M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)11.49M
Total Debt/Equity (mrq)98.42
Current Ratio (mrq)3.49
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)-14.93M
Levered Free Cash Flow (ttm)-7.92M